SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

被引：0

作者：

Schlitt, H. J. ^{[1
]}

Nashan, B. ^{[1
]}

Schemmer, P. ^{[1
]}

Pascher, A. ^{[1
]}

Klein, C. G. ^{[1
]}

Neumann, U. ^{[1
]}

Kroeger, I. ^{[2
]}

Wimmer, P. ^{[2
]}

Braun, F. ^{[1
]}

机构：

[1] Hephaistos Study Grp, Nurnberg, Germany

[2] Novartis Pharma GmbH, Nurnberg, Germany

来源：

TRANSPLANT INTERNATIONAL | 2019年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

V079

引用

页码：25 / 25

页数：1

共 50 条

[1] EFFICACY AND SAFETY OF EARLY USE OF REDUCED TACROLIMUS IN COMBINATION WITH EVEROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVERTRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
Schemmer, Peter
Braun, Felix
Schlitt, Hans J.
Pascher, Andreas
Klein, Christian-Georg
Neumann, Ulf
Kroeger, Irena
Wimmer, Peter
Nashan, Bjoern
[J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 218 - 219
[2] EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IMPROVES KIDNEY FUNCTION VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
Braun, F.
Nashan, B.
Pascher, A.
Klein, C. G.
Schemmer, P.
Neumann, U.
Kroeger, I.
Wimmer, P.
Schlitt, H. J.
[J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 24 - 24
[3] Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study
Nashan, B.
Schemmer, P.
Schlitt, H.
Pascher, A.
Klein, C.
Neumann, U.
Kroeger, I.
Wimmer, P.
Braun, F.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 333 - 333
[4] HEPHAISTOS study: Early use of everolimus plus reduced tacrolimus in de novo liver transplant recipients achieves high efficacy and safety compared to standard tacrolimus.
Schemmer, P.
Nashan, B.
Braun, F.
Pascher, A.
Klein, C. -G
Neumann, U.
Kroeger, I
Wimmer, P.
Schlitt, H. J.
[J]. TRANSPLANTATION, 2019, 103 (08) : 298 - 298
[5] Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients
Nashan, Bjorn
Schemmer, Peter
Braun, Felix
Dworak, Markus
Wimmer, Peter
Schlitt, Hans
[J]. TRANSPLANTATION, 2015, 99 : 214 - 215
[6] Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus.
Braun, F.
Schemmer, P.
Schlitt, H.
Pascher, A.
Klein, C.
Neumann, U.
Kroeger, I.
Wimmer, P.
Nashan, B.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 556 - 556
[7] Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 de Novo Liver Transplant Recipients - Results at 12 Months
De Simone, P.
Nevens, F.
Duvoux, C.
Koneru, B.
McCormack, L.
McCaughan, G.
Navasa, M.
Dong, G.
Hexham, J. M.
Junge, G.
Fung, J.
[J]. TRANSPLANTATION, 2012, 94 (10) : 750 - 750
[8] Improvement of renal function with everolimus plus reduced tacrolimus in de novo liver transplant recipients - HEPHAISTOS study 12 month data.
Schlitt, H. J.
Nashan, B.
Braun, F.
Pascher, A.
Klein, C. -G
Neumann, U.
Kroeger, I
Wimmer, P.
Schemmer, P.
[J]. TRANSPLANTATION, 2019, 103 (08) : 46 - 46
[9] The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.
De Simone, P.
Kaiser, G. M.
De Carlis, L.
Metselaar, H. J.
Duvoux, C.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
Saliba, F.
[J]. LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
[10] EARLY EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS: DESIGN AND BASELINE DATA FROM HEPHAISTOS STUDY
Nashan, B.
Schemmer, P.
Braun, F.
Dworak, M.
Wimmer, P.
Schlitt, H.
[J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S850 - S850

← 1 2 3 4 5 →